Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Girardi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Chinese Clinical Oncology|January 22, 2024
Combining cabozantinib, nivolumab and ipilimumab in advanced hepatocellular carcinoma: does benefit outweigh toxicity?Thiago A Miranda, Daniel M Girardi, Allan A L Pereira
Urologic Oncology|November 10, 2021
Systemic therapy issues: Immunotherapy in nonmetastatic urothelial cancerRosa Nadal, Andrea B Apolo, Daniel M Girardi, et al.
Urologic Oncology|November 23, 2020
Systemic therapy in bladder preservationDaniel M Girardi, Pooja Ghatalia, Parminder Singh, et al.
BMC Cancer|September 14, 2018
Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutationGustavo S Fernandes, Daniel M Girardi, João Paulo G Bernardes, et al.
Cancer Treatment Reviews|April 30, 2017
Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic reviewDaniel M Girardi, Andrea C B Silva, Juliana Florinda M Rêgo, et al.
Chinese Clinical Oncology|January 14, 2025
Advancing therapeutic frontiers in urothelial carcinoma: targeted strategies and clinical implicationsMarcela G B Guimarães, Thiago A Miranda, Fernanda N C Haum, et al.
Cancers|March 29, 2023
Systemic Therapy for Advanced Hepatocellular Carcinoma: Current Stand and PerspectivesDaniel M Girardi, Lara P Sousa, Thiago A Miranda, et al.
Journal of Gastrointestinal Cancer|September 4, 2018
Second-Line Treatment for Advanced Pancreatic Adenocarcinoma: Is There a Role for Gemcitabine?Daniel M Girardi, Luiza Dib B B Faria, Marcela C Teixeira, et al.
Pharmaceuticals (Basel, Switzerland)|January 5, 2021
Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment PerspectivesDaniel M Girardi, Jana Priscila M Pacífico, Fernanda P L Guedes de Amorim, et al.
Clinics (Sao Paulo, Brazil)|November 22, 2017
Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care?Gustavo S Fernandes, Daniel F Marques, Daniel M Girardi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Chinese Clinical Oncology|January 22, 2024
Combining cabozantinib, nivolumab and ipilimumab in advanced hepatocellular carcinoma: does benefit outweigh toxicity?Thiago A Miranda, Daniel M Girardi, Allan A L Pereira
Urologic Oncology|November 10, 2021
Systemic therapy issues: Immunotherapy in nonmetastatic urothelial cancerRosa Nadal, Andrea B Apolo, Daniel M Girardi, et al.
Urologic Oncology|November 23, 2020
Systemic therapy in bladder preservationDaniel M Girardi, Pooja Ghatalia, Parminder Singh, et al.
BMC Cancer|September 14, 2018
Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutationGustavo S Fernandes, Daniel M Girardi, João Paulo G Bernardes, et al.
Cancer Treatment Reviews|April 30, 2017
Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic reviewDaniel M Girardi, Andrea C B Silva, Juliana Florinda M Rêgo, et al.
Chinese Clinical Oncology|January 14, 2025
Advancing therapeutic frontiers in urothelial carcinoma: targeted strategies and clinical implicationsMarcela G B Guimarães, Thiago A Miranda, Fernanda N C Haum, et al.
Cancers|March 29, 2023
Systemic Therapy for Advanced Hepatocellular Carcinoma: Current Stand and PerspectivesDaniel M Girardi, Lara P Sousa, Thiago A Miranda, et al.
Journal of Gastrointestinal Cancer|September 4, 2018
Second-Line Treatment for Advanced Pancreatic Adenocarcinoma: Is There a Role for Gemcitabine?Daniel M Girardi, Luiza Dib B B Faria, Marcela C Teixeira, et al.
Pharmaceuticals (Basel, Switzerland)|January 5, 2021
Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment PerspectivesDaniel M Girardi, Jana Priscila M Pacífico, Fernanda P L Guedes de Amorim, et al.
Clinics (Sao Paulo, Brazil)|November 22, 2017
Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care?Gustavo S Fernandes, Daniel F Marques, Daniel M Girardi, et al.
Pageof 2